Lilly's ads can continue after Novo challenge, judge rules
Novo Nordisk has suffered another setback in its uphill battle against Eli Lilly in the booming obesity drug market after a US judge rejected its attempt to block television ads that Novo alleges are misleading. ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.